Risk of recurrence of primary sclerosing cholangitis after liver transplantation is associated with <i>de novo</i> inflammatory bowel disease.

World J Gastroenterol · 2018 · PMC6250922 · PMID 30487703

Europe PMC DOI

hedged sentences

0.0110

closest p · 0.2× alpha

0.1400

boldest claim

The sentences

highly significantP = 0.011actually significant

Univariate analysis identified de novo IBD as a highly significant risk factor for rPSC ( P = 0.011; OR: 22, 95%CI: 1.54-314.31) and, in line with that, recurrence-free survival was substantially ( P ≤ 0.001) higher in patients with pre-OLT IBD (median 212 mo, 95%CI: 118-212) compared with de novo IBD patients (median 72 mo, 95%CI: 36-95) (Figure 3 ).

also in 132,142 other papers

did not reach statistical significanceP = 0.140not close (p > 0.1)

However, this variant did not reach statistical significance ( P = 0.140) because of the small number of cases ( n = 4).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.